SEC Form 4 · accession 0001645627-17-000132
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Oct 20, 2017
Accepted (ET)
Oct 26, 2017 · 12:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 20, 2017 | P | 2,000 | $0.0648 | A | 23,916,189 | D | |
| Common Stock | Oct 20, 2017 | P | 2,000 | $0.065 | A | 23,918,189 | D | |
| Common Stock | Oct 20, 2017 | P | 3,000 | $0.0681 | A | 23,921,189 | D | |
| Common Stock | Oct 20, 2017 | P | 1,476 | $0.0665 | A | 23,922,665 | D | |
| Common Stock | Oct 20, 2017 | P | 1,524 | $0.0665 | A | 23,924,189 | D | |
| Common Stock | Oct 20, 2017 | P | 2,000 | $0.0665 | A | 23,926,189 | D | |
| Common Stock | Oct 20, 2017 | P | 2,000 | $0.06 | A | 23,928,189 | D | |
| Common Stock | Oct 20, 2017 | P | 2,000 | $0.06 | A | 23,930,189 | D | |
| Common Stock | Oct 20, 2017 | P | 2,000 | $0.06 | A | 23,932,189 | D | |
| Common Stock | Oct 20, 2017 | P | 2,000 | $0.0595 | A | 23,934,189 | D | |
| Common Stock | Oct 20, 2017 | P | 2,000 | $0.0594 | A | 23,936,189 | D | |
| Common Stock | Oct 20, 2017 | P | 3,000 | $0.0595 | A | 23,939,189 | D | |
| Common Stock | Oct 20, 2017 | P | 3,000 | $0.0595 | A | 23,942,189 | D | |
| Common Stock | Oct 20, 2017 | P | 2,000 | $0.0595 | A | 23,944,189 | D | |
| Common Stock | Oct 20, 2017 | P | 2,000 | $0.06 | A | 23,946,189 | D | |
| Common Stock | Oct 20, 2017 | P | 2,000 | $0.059 | A | 23,948,189 | D | |
| Common Stock | Oct 20, 2017 | P | 3,000 | $0.0547 | A | 23,951,189 | D | |
| Common Stock | Oct 20, 2017 | P | 3,000 | $0.0559 | A | 23,954,189 | D | |
| Common Stock | Oct 20, 2017 | P | 3,000 | $0.0559 | A | 23,957,189 | D | |
| Common Stock | Oct 20, 2017 | P | 3,000 | $0.0533 | A | 23,960,189 | D | |
| Common Stock | Oct 20, 2017 | P | 3,000 | $0.0521 | A | 23,963,189 | D | |
| Common Stock | Oct 20, 2017 | P | 3,000 | $0.0539 | A | 23,966,189 | D | |
| Common Stock | Oct 20, 2017 | P | 3,000 | $0.055 | A | 23,972,189 | D | |
| Common Stock | Oct 20, 2017 | P | 3,000 | $0.0556 | A | 23,975,189 | D | |
| Common Stock | Oct 20, 2017 | P | 3,000 | $0.0555 | A | 23,978,189 | D | |
| Common Stock | Oct 20, 2017 | P | 3,000 | $0.0555 | A | 23,981,189 | D | |
| Common Stock | Oct 20, 2017 | P | 3,000 | $0.0555 | A | 23,984,189 | D |
Table II — derivative securities
No Table II lines on this filing.